At What Age Should We Stop Colorectal Cancer Screening? When Is Enough, Enough?
Journal
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608
Informations de publication
Date de publication:
09 01 2023
09 01 2023
Historique:
received:
28
09
2022
revised:
01
11
2022
accepted:
22
11
2022
entrez:
9
1
2023
pubmed:
10
1
2023
medline:
11
1
2023
Statut:
ppublish
Résumé
There is strong evidence that colorectal cancer screening can reduce both colorectal cancer incidence and mortality. Guidelines recommend screening for individuals age 45 to 75 years, but are less certain about the benefits after age 75 years. Dalmat and colleagues provide evidence that individuals with a prior negative colonoscopy 10 years or more prior to reaching age 76 to 85 years, had a low risk of colorectal cancer, and would be less likely to benefit from further screening. It is important to note that this study population did not include individuals with a family history of colon cancer or a personal history of having high-risk adenomas. These data suggest that a negative colonoscopy can be an effective risk-stratification tool when discussing further screening with elderly patients. See related article by Dalmat et al., p. 37.
Identifiants
pubmed: 36620899
pii: 712623
doi: 10.1158/1055-9965.EPI-22-1006
doi:
Types de publication
Editorial
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
6-8Commentaires et corrections
Type : CommentOn
Informations de copyright
©2023 American Association for Cancer Research.